ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07CA09 | B | Diphteria toxoid purified (Prefilled syringe) - =30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - =40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml | 5394 | 23864/07 | INFANRIX HEXA | 1 x 0.5ml | Injectable suspension | IM | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 4,230,416 L.L | 23.08 | B | 2/5/2024 | 0 |